XBiotech Inc. (XBIT) Total liabilities 2018–2023
XBiotech Inc. (XBIT) total liabilities at each fiscal year-end, per SEC filings.
$7.8MFY2023 · since FY2018: $2.9M → $7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $7.8M | +36.3% |
| FY2022 | $5.7M | -1.6% |
| FY2021 | $5.8M | +13.5% |
| FY2020 | $5.1M | -91.7% |
| FY2019 | $61.2M | +1978.2% |
| FY2018 | $2.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIT financial trends
XBIT RevenueXBIT Net incomeXBIT Net marginXBIT Gross profitXBIT Gross marginXBIT Operating incomeXBIT Operating marginXBIT Operating cash flowXBIT Free cash flowXBIT Capital expendituresXBIT Return on equityXBIT Stock buybacksXBIT Dividends paidXBIT Total assetsXBIT Shareholders’ equityXBIT overview →